Elastin Peptides as a Potential Disease Vector in the Pathogenesis of Pulmonary Emphysema: An Investigation of This Hypothesis.

Jerome Cantor
Author Information
  1. Jerome Cantor: School of Pharmacy and Allied Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY 11439, USA.

Abstract

The degradation of elastic fibers is a fundamental characteristic of pulmonary emphysema, resulting in the release of proinflammatory elastin peptides. The findings discussed in this paper support the hypothesis that these peptides act as carriers of disease, interacting with elastin receptor complexes that promote inflammation, elastic fiber damage, and airspace enlargement. Studies from our laboratory show that the breakdown of these fibers is significantly enhanced by intratracheal instillation of elastin peptides in a lipopolysaccharide-induced model of acute lung injury. This result is consistent with a mechanism of elastic fiber injury in which an expanding pool of elastin peptides generates further elastolysis. The accelerating release of the peptides results in a self-perpetuating disease process with the features of an epidemic, where self-replicating agents spread disease. As in the case of an epidemic, elastin peptides resemble disease vectors that transmit alveolar wall injury throughout the lung. This concept may provide a framework for developing novel therapeutic approaches specifically designed to protect elastic fibers from various enzymatic and oxidative insults, thereby slowing the progression of a disease with no robust treatment options.

Keywords

References

  1. Lancet. 2017 May 13;389(10082):1931-1940 [PMID: 28513453]
  2. Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2304009121 [PMID: 38442161]
  3. J Clin Invest. 2006 Mar;116(3):753-9 [PMID: 16470245]
  4. Crit Rev Biomed Eng. 2011;39(4):263-80 [PMID: 22011233]
  5. J Muscle Res Cell Motil. 2002;23(5-6):561-73 [PMID: 12785105]
  6. Med Res Rev. 2013 Jun;33 Suppl 1:E73-101 [PMID: 21681767]
  7. Am J Respir Cell Mol Biol. 2020 Nov;63(5):699-706 [PMID: 32790529]
  8. Front Pharmacol. 2017 Aug 08;8:512 [PMID: 28848433]
  9. Phys Life Rev. 2016 Dec;19:43-73 [PMID: 27567502]
  10. Exp Lung Res. 1995 May-Jun;21(3):423-36 [PMID: 7621778]
  11. Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L612-31 [PMID: 18223159]
  12. Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L534-L547 [PMID: 28572155]
  13. Matrix Biol. 2020 Sep;91-92:176-187 [PMID: 32438055]
  14. Biomolecules. 2023 Mar 22;13(3): [PMID: 36979509]
  15. J Pept Res. 1997 Jun;49(6):492-9 [PMID: 9266476]
  16. ACS Biomater Sci Eng. 2023 Jul 10;9(7):3796-3809 [PMID: 34251181]
  17. Matrix Biol. 2019 Nov;84:81-96 [PMID: 31295577]
  18. Physiology (Bethesda). 2013 Nov;28(6):404-13 [PMID: 24186935]
  19. Front Endocrinol (Lausanne). 2022 Feb 11;13:815356 [PMID: 35222273]
  20. Annu Rev Pathol. 2009;4:435-59 [PMID: 18954287]
  21. Philos Trans A Math Phys Eng Sci. 2022 Jul 11;380(2227):20200410 [PMID: 35599559]
  22. Respir Med. 2021 Jun;182:106402 [PMID: 33906126]
  23. Int J Mol Sci. 2023 Feb 14;24(4): [PMID: 36835197]
  24. Expert Opin Ther Pat. 2011 Mar;21(3):339-54 [PMID: 21235378]
  25. Crit Rev Biochem Mol Biol. 2020 Jun;55(3):252-273 [PMID: 32530323]
  26. J Appl Physiol (1985). 2011 Apr;110(4):1111-8 [PMID: 21212247]
  27. Am J Respir Cell Mol Biol. 2013 Dec;49(6):971-7 [PMID: 23822858]
  28. PLoS Comput Biol. 2024 Jun 10;20(6):e1012206 [PMID: 38857274]
  29. J Toxicol Environ Health B Crit Rev. 2023 Jul 4;26(5):275-305 [PMID: 37183431]
  30. Exp Lung Res. 2005 May;31(4):417-30 [PMID: 16025922]
  31. Am J Respir Cell Mol Biol. 2014 Jul;51(1):26-33 [PMID: 24450478]
  32. Respir Care. 2018 Jun;63(6):690-698 [PMID: 29794204]
  33. Math Biosci. 2002 Nov-Dec;180:293-305 [PMID: 12387929]
  34. Front Physiol. 2019 May 28;10:664 [PMID: 31191356]
  35. Matrix Biol. 2019 Nov;84:57-67 [PMID: 31226402]
  36. Matrix Biol. 2018 Nov;73:6-20 [PMID: 29331337]
  37. Sci Rep. 2021 Feb 25;11(1):4619 [PMID: 33633290]
  38. Pathol Biol (Paris). 2012 Feb;60(1):28-33 [PMID: 22099332]
  39. Q Rev Biophys. 2024 Mar 19;57:e3 [PMID: 38501287]
  40. Am J Respir Crit Care Med. 2007 Sep 15;176(6):617-23 [PMID: 17575096]
  41. Am J Physiol Lung Cell Mol Physiol. 2024 Jun 1;326(6):L812-L820 [PMID: 38712445]
  42. Respir Med. 2012 Apr;106(4):531-9 [PMID: 22197578]
  43. Acta Biomater. 2024 Jun;181:282-296 [PMID: 38705223]
  44. Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L747-L755 [PMID: 37014816]
  45. Biophys J. 2020 Jun 2;118(11):2755-2768 [PMID: 32396850]
  46. Am J Physiol Lung Cell Mol Physiol. 2016 Jan 1;310(1):L8-23 [PMID: 26519205]

Word Cloud

Created with Highcharts 10.0.0peptideselastindiseaseelasticfibersinjurypulmonaryemphysemareleasefiberlungepidemicdegradationfundamentalcharacteristicresultingproinflammatoryfindingsdiscussedpapersupporthypothesisactcarriersinteractingreceptorcomplexespromoteinflammationdamageairspaceenlargementStudieslaboratoryshowbreakdownsignificantlyenhancedintratrachealinstillationlipopolysaccharide-inducedmodelacuteresultconsistentmechanismexpandingpoolgenerateselastolysisacceleratingresultsself-perpetuatingprocessfeaturesself-replicatingagentsspreadcaseresemblevectorstransmitalveolarwallthroughoutconceptmayprovideframeworkdevelopingnoveltherapeuticapproachesspecificallydesignedprotectvariousenzymaticoxidativeinsultstherebyslowingprogressionrobusttreatmentoptionsElastinPeptidesPotentialDiseaseVectorPathogenesisPulmonaryEmphysema:InvestigationHypothesisdesmosinevector

Similar Articles

Cited By

No available data.